Lemaître Vascular Appoints New CFO, Stock Grants
Ticker: LMAT · Form: 8-K · Filed: Apr 14, 2026
Sentiment: neutral
Topics: executive-appointment, cfo, compensation
TL;DR
Lemaître Vascular names David Roberts new CFO, starting April 15th, with stock grants.
AI Summary
On April 8, 2026, Lemaître Vascular, Inc. announced the appointment of David L. Roberts as Chief Financial Officer, effective April 15, 2026. Roberts will receive an annual base salary of $350,000 and is eligible for a discretionary annual bonus. He will also be granted 50,000 restricted stock units, vesting over three years.
Why It Matters
The appointment of a new CFO is a significant leadership change that could impact the company's financial strategy and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key executive positions like CFO can introduce uncertainty regarding future financial strategy and performance.
Key Numbers
- $350,000 — CFO Base Salary (Annual compensation for David L. Roberts)
- 50,000 — RSUs Granted (Stock units awarded to the new CFO vesting over three years)
Key Players & Entities
- Lemaître Vascular, Inc. (company) — Company filing the report
- David L. Roberts (person) — Newly appointed Chief Financial Officer
- $350,000 (dollar_amount) — Annual base salary for new CFO
- 50,000 (dollar_amount) — Number of restricted stock units granted to new CFO
- April 15, 2026 (date) — Effective date of new CFO's appointment
- April 8, 2026 (date) — Period of report for the filing
FAQ
Who has been appointed as the new Chief Financial Officer of Lemaître Vascular, Inc.?
David L. Roberts has been appointed as the new Chief Financial Officer.
When is David L. Roberts' appointment as CFO effective?
The appointment is effective April 15, 2026.
What is the annual base salary for the new CFO?
The annual base salary for David L. Roberts is $350,000.
What stock-based compensation is the new CFO receiving?
David L. Roberts will be granted 50,000 restricted stock units, which will vest over three years.
What other compensation is the new CFO eligible for?
David L. Roberts is eligible for a discretionary annual bonus.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2026 by David L. Roberts regarding LEMAITRE VASCULAR INC (LMAT).